CheckMate 067: Phase 3 trial of nivolumab in melanoma - European Medical Journal

Continue

CheckMate 067: Phase 3 trial of nivolumab in melanoma

Oncology
University of Nebraska Medical Center, Omaha, NE, discusses the phase 3 CheckMate 067 trial of nivolumab alone or combined with ipilimumab versus ipilimumab alone in treatment-naive patients with advanced melanoma.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?